Cargando…

Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention

The most common cause of antibiotic-associated diarrhea is Clostridium difficile infection (CDI). Recurrent C. difficile infection (rCDI) often occurs after successful treatment of CDI. Due to the increased incidence and the difficulty in treating rCDI, it is becoming an important clinical issue. Id...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jung Hoon, Kim, You Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346998/
https://www.ncbi.nlm.nih.gov/pubmed/30400734
http://dx.doi.org/10.5009/gnl18071
_version_ 1783389867600773120
author Song, Jung Hoon
Kim, You Sun
author_facet Song, Jung Hoon
Kim, You Sun
author_sort Song, Jung Hoon
collection PubMed
description The most common cause of antibiotic-associated diarrhea is Clostridium difficile infection (CDI). Recurrent C. difficile infection (rCDI) often occurs after successful treatment of CDI. Due to the increased incidence and the difficulty in treating rCDI, it is becoming an important clinical issue. Identifying risk factors is helpful for early detection, treatment, and prevention of rCDI. Advanced age, use of antibiotics, gastric acid suppression, and infection with a hypervirulent strain are currently regarded as the major risk factors for rCDI. Several treatment modalities, including vancomycin, fidaxomicin, and fecal microbiota transplant (FMT), are suggested for rCDI treatment. However, there is currently no definitive treatment method with sufficient evidence for rCDI. Recent studies have focused on FMT and have shown positive results for rCDI. Prevention of rCDI by measures such as hand washing and isolation of patients is very important. However, these preventive measures are often overlooked in clinical practice. Here, we review the risk factors, treatment, and prevention of rCDI.
format Online
Article
Text
id pubmed-6346998
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Editorial Office of Gut and Liver
record_format MEDLINE/PubMed
spelling pubmed-63469982019-02-04 Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention Song, Jung Hoon Kim, You Sun Gut Liver Review The most common cause of antibiotic-associated diarrhea is Clostridium difficile infection (CDI). Recurrent C. difficile infection (rCDI) often occurs after successful treatment of CDI. Due to the increased incidence and the difficulty in treating rCDI, it is becoming an important clinical issue. Identifying risk factors is helpful for early detection, treatment, and prevention of rCDI. Advanced age, use of antibiotics, gastric acid suppression, and infection with a hypervirulent strain are currently regarded as the major risk factors for rCDI. Several treatment modalities, including vancomycin, fidaxomicin, and fecal microbiota transplant (FMT), are suggested for rCDI treatment. However, there is currently no definitive treatment method with sufficient evidence for rCDI. Recent studies have focused on FMT and have shown positive results for rCDI. Prevention of rCDI by measures such as hand washing and isolation of patients is very important. However, these preventive measures are often overlooked in clinical practice. Here, we review the risk factors, treatment, and prevention of rCDI. Editorial Office of Gut and Liver 2019-01 2018-10-30 /pmc/articles/PMC6346998/ /pubmed/30400734 http://dx.doi.org/10.5009/gnl18071 Text en Copyright © 2019 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Song, Jung Hoon
Kim, You Sun
Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
title Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
title_full Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
title_fullStr Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
title_full_unstemmed Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
title_short Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
title_sort recurrent clostridium difficile infection: risk factors, treatment, and prevention
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346998/
https://www.ncbi.nlm.nih.gov/pubmed/30400734
http://dx.doi.org/10.5009/gnl18071
work_keys_str_mv AT songjunghoon recurrentclostridiumdifficileinfectionriskfactorstreatmentandprevention
AT kimyousun recurrentclostridiumdifficileinfectionriskfactorstreatmentandprevention